Administration of aggregated beta-amyloid peptide (25-35) induces changes in long-term potentiation in the hippocampus in vivo.

Neuroscience and behavioral physiology

Volumn 33, Issue 2, 2003, Pages 95-98

  Trubetskaya, V V ^a   Stepanichev, M Y ^a   Onufriev, M V ^a   Lazareva, N A ^a   Markevich, V A ^a   Gulyaeva, N V ^a  

^a INSTITUTE OF HIGHER NERVOUS ACTIVITY AND NEUROPHYSIOLOGY   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN (25 35); AMYLOID BETA-PROTEIN (25-35); PEPTIDE FRAGMENT;

ANIMAL; ARTICLE; DRUG EFFECT; HIPPOCAMPUS; LONG TERM POTENTIATION; MALE; PHYSIOLOGY; RAT; WISTAR RAT;

AMYLOID BETA-PROTEIN; ANIMALS; HIPPOCAMPUS; LONG-TERM POTENTIATION; MALE; PEPTIDE FRAGMENTS; RATS; RATS, WISTAR;

EID: 0037314455     PISSN: 00970549     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1021761310435     Document Type: Article

References (0)